Capstone Investment Advisors
LMDXW

Capstone Investment Advisors’s LumiraDx Limited Warrant LMDXW Stock Holding History

Capstone Investment Advisors’s Portfolio LMDXW Stock Details LMDXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-35,000
Closed -$33K – 1845
2022
Q2 		$33K Hold
35,000
– – ﹤0.01% 1639
2022
Q1 		$31K Hold
35,000
– – ﹤0.01% 1911
2021
Q4 		$63K Hold
35,000
– – ﹤0.01% 1654
2021
Q3 		$41K Buy
+35,000
New +$40.6K ﹤0.01% 1859

Other funds holding LMDXW

CH
CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Capstone Investment Advisors's LMDXW Position: Q3 2022 in Review

Capstone Investment Advisors sold out of LumiraDx Limited Warrant (LMDXW) in Q3 2022, closing a stake of 35,000 shares — an estimated $33K sold.

Capstone Investment Advisors first reported a position in LMDXW in Q3 2021 and held it in 4 quarters. The position peaked at $63K in Q4 2021. 21 funds tracked by Wall St. Rank hold LMDXW as of Q3 2022.

  • Capstone Investment Advisors reported no remaining LumiraDx Limited Warrant position as of Q3 2022 after selling out during the quarter.
  • Capstone Investment Advisors sold 35,000 LumiraDx Limited Warrant shares in Q3 2022, an estimated $33K.
  • Capstone Investment Advisors first reported a position in LumiraDx Limited Warrant in Q3 2021 and held it in 4 quarters.
  • Capstone Investment Advisors's LumiraDx Limited Warrant position peaked at $63K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q3 2022.

Based on Capstone Investment Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.